Belano, Manilyn S.
HRN: 27-16-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2025
CEFUROXIME 750MG (VIAL)
11/09/2025
11/15/2025
IV
750mg
PTOR Then Q8
Anterior Neck Mass, For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes